Bioteknik: "With or without any doubts about the BOD, ...."
I fully agree that CYP's share-price should be going 'skywards'. However, an either good or alternatively a somewhat doubtful BOD will have in fact quite a CRUCIAL effect upon the kind of re-rating that a stock makes. JIMHO, of course.
wasa
Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints, page-36
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7339 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 07.02am 26/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable